Cargando…

Twenty-four-color full spectrum flow cytometry panel for minimal residual disease detection in acute myeloid leukemia

Full spectrum flow cytometry brings a breakthrough for minimal residual disease (MRD) detection in acute myeloid leukemia (AML). We aimed to explore the role of a new panel in MRD detection. We established a 24-color full-spectrum flow cytometry panel. A tube of 24-color antibodies included CD45, CD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Man, Fu, Minjing, Gong, Meiwei, Gao, Yajing, Wang, Aixian, Zhao, Wei, Wu, Xueying, Wang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390751/ https://www.ncbi.nlm.nih.gov/pubmed/37533738 http://dx.doi.org/10.1515/med-2023-0745

Ejemplares similares

Abnormalities by Multicolor Flow Cytometry for Detection of Minimal Residual Disease in Recipients of Allo-HSCT Originating from Donors: A Cohort Study
por: Wang, Hui, et al.
Publicado: (2023)

FACSorting help to analyze a rare case of acute myeloid leukemia with concurrent AML1‐ETO and PML‐RARA
por: Chen, Man, et al.
Publicado: (2021)

Updating recommendations of the Brazilian Group of Flow Cytometry (GBCFLUX) for diagnosis of acute leukemias using four-color flow cytometry panels
por: Beltrame, Míriam P., et al.
Publicado: (2021)

Full spectrum flow cytometry and mass cytometry: A 32‐marker panel comparison
por: Jaimes, Maria C., et al.
Publicado: (2022)

Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid Leukemia
por: Vial, Jean Philippe, et al.
Publicado: (2021)

OMIP‐069: Forty‐Color Full Spectrum Flow Cytometry Panel for Deep Immunophenotyping of Major Cell Subsets in Human Peripheral Blood
por: Park, Lily M., et al.
Publicado: (2020)

Clinical Analysis and Optimization of Postremission Therapy for Acute Myeloid Leukemia Patients with Minimal Residual Disease as Determined by Flow Cytometry.
por: Inoue, Daichi, et al.
Publicado: (2010)

Mouse dendritic cells and other myeloid subtypes in healthy lymph nodes and skin: 26‐Color flow cytometry panel for immune phenotyping
por: Hornsteiner, Florian, et al.
Publicado: (2022)

Standardized 11-color flow cytometry panel for the functional phenotyping of human T regulatory cells
por: Manuszak, Claire, et al.
Publicado: (2020)

Pre- and Post-Transplant Quantification of Measurable (“Minimal”) Residual Disease via Multiparameter Flow Cytometry in Adult Acute Myeloid Leukemia
por: Zhou, Yi, et al.
Publicado: (2016)

Multi-color Flow Cytometry Protocol to Characterize Myeloid Cells in Mouse Retina Research
por: Xiao, Wei, et al.
Publicado: (2023)

Twenty-four caprices in the twenty-four major and minos keys for the violin
por: Rode, Pierre, 1774-1830
Publicado: (1943)

The utility of multiparametric flow cytometry for the detection of minimal residual disease in acute lymphoblastic leukemia
por: Cunha, Fernanda Gonçalves Pereira, et al.
Publicado: (2012)

Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma
por: Foureau, David, et al.
Publicado: (2021)

Standardizing Clinical Workflow for Assessing Minimal Residual Disease by Flow Cytometry in Multiple Myeloma
por: Foureau, David M., et al.
Publicado: (2023)

Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia
por: Röhnert, Maximilian A., et al.
Publicado: (2022)

Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemia
por: Norkin, Maxim, et al.
Publicado: (2017)

Liquid biopsies and minimal residual disease in myeloid malignancies
por: Allam, Sabine, et al.
Publicado: (2023)

Titrating Complex Mass Cytometry Panels
por: Gullaksen, Stein‐Erik, et al.
Publicado: (2019)

Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)
por: Patkar, Nikhil, et al.
Publicado: (2021)

Proposal for the standardization of flow cytometry protocols to detect minimal residual disease in acute lymphoblastic leukemia
por: Ikoma, Maura Rosane Valério, et al.
Publicado: (2015)

Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis
por: Kastritis, Efstathios, et al.
Publicado: (2018)

Minimal residual disease assessment in acute lymphoblastic leukemia by 4-color flow cytometry: Recommendations from the MRD Working Group of the Brazilian Society of Bone Marrow Transplantation
por: Ikoma-Colturato, Maura R.V., et al.
Publicado: (2021)

Eight‐color multiparameter flow cytometry (EuroFlow‐NGF) is as sensitive as next‐generation sequencing in detecting minimal/measurable residual disease in autografts of patients with multiple myeloma
por: Urushihara, Ryota, et al.
Publicado: (2023)

Angiogenesis and Minimal Residual Disease in Patients with Acute Myeloid Leukemia
por: Nematollahi, Pardis, et al.
Publicado: (2020)

Molecular Minimal Residual Disease Detection in Acute Myeloid Leukemia
por: Vonk, Christian M., et al.
Publicado: (2021)

Functional phenotyping of circulating human cytotoxic T cells and NK cells using a 16-color flow cytometry panel
por: Baracho, Gisele V., et al.
Publicado: (2021)

OMIP 083: A 21‐marker 18‐color flow cytometry panel for in‐depth phenotyping of human peripheral monocytes
por: Hally, Kathryn E., et al.
Publicado: (2022)

P853: AUTOMATED SEPARATION OF CELL CLUSTERS PROVIDES AN EASY AND ACCURATE STRATEGY FOR THE ANALYSIS OF MINIMAL RESIDUAL DISEASE IN MULTIPLE MIELOMA IN SINGLE 11-COLORS FLOW CYTOMETRY COMBINATION.
por: Piñero, Paula, et al.
Publicado: (2023)

Flow Cytometry and Polymerase Chain Reaction-Based Analyses of Minimal Residual Disease in Chronic Lymphocytic Leukemia
por: Uhrmacher, Sabrina, et al.
Publicado: (2010)

Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myeloma
por: Dold, Sandra Maria, et al.
Publicado: (2020)

Minimal residual disease detection by multicolor flow cytometry in cryopreserved ovarian tissue from leukemia patients
por: Zver, Tristan, et al.
Publicado: (2022)

Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design
por: Aguilera-Diaz, Almudena, et al.
Publicado: (2020)

Experimental and Theoretical Modal Analysis of Full-Sized Wood Composite Panels Supported on Four Nodes
por: Guan, Cheng, et al.
Publicado: (2017)

Re-Emergence of Minimal Residual Disease Detected by Flow Cytometry Predicts an Adverse Outcome in Pediatric Acute Lymphoblastic Leukemia
por: Wang, Yu, et al.
Publicado: (2021)

Color-scalable flow cytometry with Raman tags
por: Nishiyama, Ryo, et al.
Publicado: (2023)

Measurable Residual Disease Detected by Multiparameter Flow Cytometry and Sequencing Improves Prediction of Relapse and Survival in Acute Myeloid Leukemia
por: Liu, Fu-Jia, et al.
Publicado: (2021)

Quality of Response in Acute Myeloid Leukemia: The Role of Minimal Residual Disease
por: Maurillo, Luca, et al.
Publicado: (2019)

Twenty-four caprices for the violin : [Op. 1]
por: Paganini, Nicolo, 1782-1840
Publicado: (1944)

Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis
por: Palladini, Giovanni, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5lghqp0rpol7o0avks018jnodu